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High concentrations of airborne particles have
been associated with increased pulmonary and
cardiovascular mortality, with indications of a
speciﬁc toxicologic role for ultraﬁne particles
(UFPs; particles with diameters < 0.1 µm)
(Peters et al. 1997). UFPs may induce inﬂam-
matory and prothrombotic responses, promot-
ing atherosclerosis, thrombogenesis, and the
occurrence of other cardiovascular events
(Schulz et al. 2005). Human data suggest that
inhaled UFPs influence lung physiology
(Pietropaoli etal. 2004). UPFs may also affect
the autonomic nervous system or act directly
on cells in various organs and induce muta-
tions (Harder etal. 2005; Samet etal. 2004).
After exposure of the respiratory system to
UFPs, the UFPs may appear within hours in
many compartments of the body, including
the liver, heart, and nervous system (Brown
etal. 2002; Kreyling etal. 2002; Oberdörster
etal. 2004).
UFPs are formed by gas-to-particle con-
version or by incomplete fuel combustion.
Despite considerable efforts to reduce air pol-
lution, the environmental burden by UFPs
may have increased rather than decreased over
time (Kreyling etal. 2003). Moreover, the
fast-growing nanotechnology industry gener-
ates new UFPs daily, which may become
aerosolized at some stage and may present
additional health risks. UFPs possess increased
toxicity compared with larger particles com-
posed of the same materials (Ferin etal. 1992).
Their environmental burden is characterized
by high number concentrations but low mass
concentrations. Thus, a relatively large surface
area per unit mass facilitates adsorption of vari-
ous organic compounds from the ambient air
and enhances interaction with biological mole-
cules within the organism.
Deposition of UFPs in the respiratory sys-
tem is caused by diffusional displacement.
Depending on particle size, deposition occurs
efﬁciently in the nose, the conducting airways,
and the alveoli. Although particles with diam-
eters > 1 µm usually remain on the epithelial
surface upon their deposition (Gehr etal.
1990; Geiser etal. 2003; Schürch etal. 1990)
and are subjected to clearance by cough,
mucociliary transport, and/or phagocytosis by
macrophages, UFPs seem to penetrate the
boundary membranes of the lungs rapidly—a
unique feature for insoluble particles (Brown
etal. 2002; Kreyling etal. 2002; Oberdörster
etal. 2002). In addition, transport across the
olfactory epithelium and accumulation in the
brain were reported for various UFP types
(Oberdörster 2004). In vitro experiments
revealed penetration of UFPs into mito-
chondria of macrophages and epithelial cells
that was associated with oxidative stress and
mitochondrial damage (Li etal. 2003). 
Because everyone on earth inevitably
inhales thousands to millions of UFPs with
each breath, it is important to assess health
risks by UFP air pollution. The costs of actions
to be taken to reduce ambient aerosol particles
are high and will affect the economy greatly,
presenting an urgent need to clarify the fate of
inhaled UFPs. To date, the mechanisms by
which UFPs penetrate boundary membranes
and the distribution of UFPs within tissue
compartments of their primary and secondary
target organs are largely unknown.
This study is the first to investigate the
distribution of inhaled UFPs within lungs at
the individual particle level and combines dif-
ferent experimental approaches—an in vivo
inhalation study in rats and an in vitro cell
exposure study on pulmonary macrophages
and red blood cells (RBCs).
In the in vivo experiments, rats inhaled an
ultrafine titanium dioxide aerosol of 22 nm
count median diameter (CMD) during 1 hr,
resulting in a deposition of 4–5 µg TiO2 per
animal. The intrapulmonary distribution of
deposited particles was analyzed immediately or
24 hr after the end of exposure, using energy-
filtering transmission electron microscopy
(EFTEM) to allow elemental microanalysis of
individual particles (Kapp etal. 2004).
In the in vitro study, we exposed cultured
porcine pulmonary macrophages and human
RBCs to ﬂuorescent polystyrene microspheres
with diameters of 1, 0.2, and 0.078 µm and
assessed particle uptake by confocal laser
scanning microscopy (CLSM).
Materials and Methods
Animals. The animal experiments were con-
ducted under federal guidelines for the use and
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High concentrations of airborne particles have been associated with increased pulmonary and cardio-
vascular mortality, with indications of a specific toxicologic role for ultrafine particles (UFPs;
particles < 0.1 µm). Within hours after the respiratory system is exposed to UFPs, the UFPs may
appear in many compartments of the body, including the liver, heart, and nervous system. To date,
the mechanisms by which UFPs penetrate boundary membranes and the distribution of UFPs
within tissue compartments of their primary and secondary target organs are largely unknown. We
combined different experimental approaches to study the distribution of UFPs in lungs and their
uptake by cells. In the in vivo experiments, rats inhaled an ultraﬁne titanium dioxide aerosol of 22
nm count median diameter. The intrapulmonary distribution of particles was analyzed 1 hr or 24 hr
after the end of exposure, using energy-filtering transmission electron microscopy for elemental
microanalysis of individual particles. In an in vitro study, we exposed pulmonary macrophages and
red blood cells to ﬂuorescent polystyrene microspheres (1, 0.2, and 0.078 µm) and assessed particle
uptake by confocal laser scanning microscopy. Inhaled ultrafine titanium dioxide particles were
found on the luminal side of airways and alveoli, in all major lung tissue compartments and cells,
and within capillaries. Particle uptake in vitro into cells did not occur by any of the expected endo-
cytic processes, but rather by diffusion or adhesive interactions. Particles within cells are not mem-
brane bound and hence have direct access to intracellular proteins, organelles, and DNA, which may
greatly enhance their toxic potential. Key words: aerosol, erythrocytes, lungs, macrophages,
microscopy, nanoparticles, rats, surfactant. Environ Health Perspect 113:1555–1560 (2005).
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care of laboratory animals (German Animal
Protection Law) and were approved by the
District of Upper Bavaria (Approval No. 211-
2531-108/99) and by the GSF Institutional
Animal Care and Use Committee, as well as in
accordance with the Swiss Federal Act on
Animal Protection and the Swiss Animal
Protection Ordinance. Ten young, adult, male
WKY/NCrl BR rats [body weight (bw)
250 ± 10 g (mean ± SD; Charles River,
Sulzfeld, Germany] were housed under stan-
dard conditions, with access to food and water
ad libitum, in a room controlled for humidity
(55% relative humidity) and temperature
(22°C) and with lighting on a 12-hr day/night
cycle. Animals were anesthetized by intra-
muscular injection of a mixture of medetomi-
dine (Domitor; 150 µg/100 g bw; Pfizer
GmbH, Karlsruhe, Germany), midazolam
(Dormicum; 0.2 mg/100 g bw; Hoffmann-La
Roche AG, Grenzach-Wyhlen, Germany), and
Fentanyl (0.5 µg/100 g bw; Janssen-Cilag
GmbH, Neuss, Germany) for inhalation and
lung fixation and anticoagulated by intra-
peritoneal injection of 2,000 IU heparin
(Heparin-Natrium-ratiopharm, ratiopharm
GmbH, Ulm/Donautal, Germany) for lung
fixation (Kapp etal. 2004). Anesthesia was
antagonized by subcutaneous injection of
atipamezole (Antisedan; Pfizer GmbH),
flumazenil (Anexate, Hoffmann-La Roche
AG), and naloxone (Narcanti, Janssen Animal
Health, Neuss, Germany).
Aerosols and inhalation. Titanium is suit-
able for EFTEM because it does not interfere
with the heavy metals used for tissue prepara-
tion (Kapp etal. 2004). TiO2 is inert and
nonpathogenic (Templeton 1994), and ultra-
ﬁne aerosols thereof remain as insoluble parti-
cles (Donaldson etal. 2002). Generally,
commercially available TiO2 particles
(Degussa, Düsseldorf, Germany) show a posi-
tive Zeta potential of 20–30 mV as measured
by Malvern Zetasizer 3000 HS (Malvern
Instruments Ltd., Malvern, Worcestershire,
UK) The generation and inhalation of the
TiO2 aerosol used in this study has been
described in detail by Kapp etal. (2004).
Brieﬂy, ultraﬁne TiO2 aerosols were generated
with a Palas spark generator (Palas GmbH,
Karlsruhe, Germany) in a pure argon plus
0.1% oxygen stream. The aerosol was quasi-
neutralized by a radioactive 85Kr source,
diluted, and conditioned for inhalation.
Particle size distribution and number concen-
tration were monitored continuously by a dif-
ferential electrical mobility particle sizer and a
condensation particle counter. An aerosol of
22 nm CMD (geometric SD of 1.7) was pro-
duced. The mean number concentration was
7.3 × 106 particles/cm3 (SD 0.5 × 106 par-
ticles/cm3), corresponding to a mass concen-
tration of 0.11 mg/m3. The 22 nm particles
measured as aerosol particles are already
agglomerates of smaller primary structures
formed immediately after spark ignition and
condensation. The estimated size of the pri-
mary structures was 4 nm as derived from the
measured speciﬁc surface area of 330 m2/g of
the UFPs produced in this study and the TiO2
bulk density of 4.2 g/cm3.
Each anesthetized rat was placed in an air-
tight plethysmograph box. The animals
inhaled the aerosol in pairs (one each for the
1-hr and 24-hr examinations) for 1 hr via an
endotracheal tube by negative-pressure venti-
lation (–1.5 Pa) at a breathing frequency of
45/min, resulting in a minute volume of
about 200 cm3/min (Kreyling etal. 2002).
From breathing and aerosol parameters,
the deposited amount of TiO2 was calculated
to be 4–5 µg in each rat. After aerosol expo-
sure, anesthesia of one of the paired rats was
antagonized as described above, and the ani-
mal was returned to its cage for 24 hr.
Lung fixation and tissue preparation.
Lungs were ﬁxed either 1 hr or 24 hr after the
aerosol inhalation by sequential intravascular
perfusion with buffered 2.5% glutaraldehyde
(Agar Scientiﬁc Ltd., Plano GmbH, Wetzlar,
Germany), 1.0% osmium tetroxide (Simec,
Zofingen, Switzerland), and 0.5% uranyl
acetate (Fluka Chemie GmbH, Sigma-
Aldrich, Buchs, Switzerland). Lungs were
then subjected to systematic tissue sampling,
dehydration in a graded series of ethanol, and
embedding in Epon (Fluka) (Im Hof etal.
1989; Kapp etal. 2004). Ultrathin (≤ 50 nm)
sections were cut from five to eight tissue
blocks per animal, mounted onto uncoated
600-mesh copper grids, and stained with
uranyl acetate and lead citrate (Ultrostain,
Leica, Glattbrugg, Switzerland). 
Particle localization and elemental micro-
analysis in situ. On ultrathin sections,
12 fields, corresponding to an area of
1,820 µm2 each, were systematically sub-
sampled and investigated for the presence and
localization of TiO2 particles in a LEO 912
transmission electron microscope (LEO,
Oberkochen, Germany) equipped with an in-
column energy filter allowing energy disper-
sion for element specific contrast. TiO2
particles were identified by parallel electron
energy-loss spectroscopy (parallel-EELS), elec-
tron spectroscopic imaging, and image-EELS
(Kapp etal. 2004). For elemental micro-
analysis, we used the L2,3 edge of Ti at
456 eV energy loss. We obtained bright-ﬁeld
and structure-sensitive micrographs (recorded
at 250 eV), as well as element-specific con-
trast for TiO2, by digital acquisition.
Cell culture experiments. Porcine lung
macrophages (provided by K. McCullough
and H. Gerber, Institute for Virus Diseases
and Immune Prophylaxis, Mittelhäusern,
Switzerland) were cultured at 106 cells/mL in
two-chamber slides (VWR International AG,
Dietikon, Switzerland) for 24 hr at 37°C and
5% CO2 in RPMI 1640 medium (containing
25 mM Hepes; LabForce AG, Nunningen,
Switzerland) with 10% fetal bovine serum
(LabForce), 1% L-glutamine (LabForce), and
1% penicillin/streptomycin (Gibco BRL,
Invitrogen AG, Basel, Switzerland). Human
RBCs, always freshly isolated from the same
donor, were cultured at 8 × 106 cells/mL and
for 6–24 hr, as described above.
For CLSM, fluorescent polystyrene
microspheres with diameters of 1, 0.2, and
0.078 µm (Fluoresbrite plain yellow green;
Polysciences, Chemie Brunschwig AG, Basel,
Switzerland) were added to the cells at 1010
particles/ mL in supplement-free RPMI 1640
medium for 4 hr. To inhibit phagocytic
uptake, cells were pretreated with cyto-
chalasin D (cytD, 10 µg/mL; Fluka) for
30 min and during incubation with particles
(Thiele etal. 2001). Macrophages were then
washed in phosphate-buffered saline (PBS),
fixed in 3% paraformaldehyde/PBS, treated
with 0.1 M glycine/PBS, permeabilized with
0.2% Triton X-100/PBS, and stained for
F-actin with rhodamine-phalloidin (1:100;
Molecular Probes, VWR International AG,
Lucerne, Switzerland) for 60 min at 37°C.
RBCs were ﬁxed in 2.5% glutaraldehyde/PBS,
resulting in a red autofluorescence. Prep-
arations were mounted in PBS:glycerol (2:1)
containing 170 mg/mL Mowiol 4-88
(Calbiochem, VWR International AG).
For TEM analysis, RBCs were incubated
with 0.025 µm gold particles (ANAWA
Trading SA, Wangen, Switzerland) at 6.6 ×
1010 particles/mL. RBCs were fixed with
buffered 2.5% glutaraldehyde, 1% osmium
tetroxide, and 0.5% uranyl acetate, and pre-
pared for TEM as described above for lung
tissue.
Microscopic analysis of cultured cells. We
used a MicroRadiance system from Bio-Rad
(Hemel Hempstead, UK) combined with an
inverted Nikon microscope (Eclipse TE3000;
lasers: GHe/Ne 543 nm and Ar 488 nm)
(Nikon, Küsnacht, Switzerland). Optical sec-
tions with a voxel dimension of 50 × 50 ×
200 nm were taken with a 100×/1.4 plan-
apochromate objective. We performed image
processing and visualization using IMARIS
software (Bitplane AG, Zurich, Switzerland).
We applied a deconvolution algorithm
using Huygens2 software (Scientific Volume
Imaging B.V., Hilversum, Netherlands) to
increase axial and lateral resolutions and to
decrease noise (Rothen-Rutishauser etal.
1998). Experiments were performed in
triplicate or quadruplicate, and 30–50 cells
were scanned by CLSM for each data
point. We examined ultrathin sections of
RBCs incubated with gold particles in a
Philips 300 TEM at 60 kV (Philips,
Zurich, Switzerland).Results
Distribution of inhaled UFPs in lungs. We
found TiO2 particles on the luminal side of
airways and alveoli as well as within each tissue
compartment of the lung (Figures 1 and 2).
Particles were localized within epithelial and
endothelial cells, within fibroblasts and
between collagen ﬁbrils in the connective tis-
sue, within blood capillaries, and even within
RBCs (Figure 1). Intracellular particles were
localized most often in the cytoplasm and
rarely within the nucleus. Particles within cells
were not membrane bound. On average,
79.3 ± 7.6% (mean ± SD) of the particles
were found on the luminal side of airways and
alveoli, 4.6 ± 2.5% were within epithelial or
endothelial cells, 4.8 ± 4.5% within the con-
nective tissue, and 11.3 ± 3.9% within the
capillaries. The relative distributions of parti-
cles among different lung compartments at
1 hr and at 24 hr after inhalation were not dif-
ferent from each other and correlated with the
volume fractions of the respective compart-
ments (Figure 2).
Uptake of UFPs by macrophages and
RBCs. We studied the uptake of fine
(1–0.2 µm) and ultraﬁne (< 0.1 µm) ﬂuores-
cent microspheres in cultured macrophages as
a model for phagocytic cells and in human
RBCs as a model for nonphagocytic cells.
Additionally, we treated macrophage cultures
with cytD to block phagocytosis. Cells were
prepared for CLSM, and a deconvolution
algorithm was applied to increase lateral as
well as axial resolution. We found particles of
all sizes within macrophages (Figure 3A), how-
ever, with different percentages of cells
involved in particle uptake. On average,
77 ± 15% (mean ± SD) of the macrophages
contained UFPs, 21 ± 11% contained 0.2 µm
particles, and 56 ± 30% contained 1 µm par-
ticles (Figure 3B). CytD did not inhibit the
uptake of ultrafine and 0.2 µm particles but
blocked the uptake of 1 µm particles by these
cells (Figure 3B). We found ultrafine and
0.2 µm, but not 1 µm, particles in RBCs
(Figure 4A). TEM analysis of RBCs incubated
with 0.025 µm gold particles showed that
intracellular particles were not membrane
bound (Figure 4B).
Discussion
The ultrastructural analyses of lung tissue
demonstrated that 1 hr after aerosol inhala-
tion, 24% of ultraﬁne TiO2 particles, on aver-
age, were located within and beyond the
epithelial barrier (i.e., in the main lung tissue
compartments, in the cytoplasm, and in the
nucleus of the cells). These results confirm
data from human studies, where the inhala-
tion of ultraﬁne carbon particles affected pul-
monary diffusing capacity (Pietropaoli etal.
2004), suggesting that particles in the inters-
titium have physiologic effects.
This study also provides evidence for
some particle translocation into the micro-
vasculature. In previous studies on iridium
particles, we found minute fractions of parti-
cles translocated into secondary target organs
(Kreyling etal. 2002; Semmler etal. 2004b).
Different particle materials—iridium versus
TiO2—may have resulted in different particle
translocation patterns, and we do not know
the exact composition and structure of the
Ultrafine particle distribution in lungs
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Figure 1. EFTEM micrographs of particles (arrows)
in the lung parenchyma. Abbreviations: AL, alveo-
lar lumen; C, collagen fibril; CL, capillary lumen;
EC, erythrocyte; EN, capillary endothelial cell;
EOS, eosinophil granulocyte; EP, epithelium; F,
ﬁbroblast; FC, ﬁbroblast cytoplasm; FN, ﬁbroblast
nucleus. (A) Particle (diameter, 85 nm) in the con-
nective tissue between Cs. (B) Particle (diameter,
41 nm) in the FC near its FN. (C) Particle (diameter,
81 nm) in the cytoplasm of an EN. (D) Particle
(diameter, 41 nm) within an EC in the CL.
(E) Particle (diameter, 50 nm) within the FN. Bars =
500 nm.
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Figure 2. Relative distribution of particles localized in
the different lung compartments at 1 hr and 24 hr
after inhalation. Volume densities (Vv) for lung tissue
compartments from Burri et al. (1973), Pinkerton
et al. (1992), and Tschanz et al. (1995, 2003).ultrafine particle surface, which is likely to
influence particle translocation. The present
study focuses on particle distribution within
the primary target organ, the lung, and the
results do not determine which fraction of
particles may have escaped the lung micro-
vasculature to be systemically circulated.
Particles found within cells were not mem-
brane bound, indicating a nonendocytic
uptake. In addition, the overall distribution
pattern of the particles in the lungs (i.e., the
percentages of particles in the different lung
compartments) at 1 hr and at 24 hr after parti-
cle inhalation was the same and was correlated
with the volume densities of the correspond-
ing lung compartments, implying that ultra-
fine TiO2 particles can move between tissue
compartments without restraint. Our results
are in contrast with those obtained by Stearns
etal. (2001), who studied the uptake of ultra-
fine TiO2 particles in vitro in the A549
epithelial cell line. They found that mem-
brane-bound vesicles contained mostly large
aggregates of TiO2. Sometimes vesicles with
clusters consisting of as few as two to three
particle profiles were observed. In a pilot
study in vitro with porcine macrophages, we
obtained similar results (data not shown).
Whether these clusters contained few particles
only or were sectioned through the top of
larger ones is not known. However, because
ultraﬁne TiO2 aggregate very quickly in polar
liquids such as cell culture medium and
because particle concentration was fairly high,
as seen from micrographs, it is very likely that
particles aggregated within the cell culture
medium and that cells engulfed these large
clusters by an endocytic pathway. Particle
agglomeration on the lung epithelium during
the 1-hr inhalation, however, is very unlikely
because of the size of the inner lung surface
and the number of deposited UFPs.
The fact that 80% of the retained TiO2
particles were still on the luminal side of the
epithelium even 24 hr after inhalation is sur-
prising and in contrast to previous studies on
the lavageability of ultraﬁne iridium particles,
where only 20% of the particles could be
lavaged from the epithelial surfaces 24 hr after
inhalation (Kreyling etal. 2002). The low
lavageability of ultrafine iridium particles in
contrast to high lavageability of 80% of
0.5–10-µm particles (Oberdörster etal. 2002)
was interpreted as either higher adhesion of
UFPs to epithelial membranes or epithelial
uptake and penetration of UFPs into the
interstitium. The large fraction of TiO2 par-
ticles on the luminal side of the epithelium in
the present study strongly supports higher
adhesion of UFPs to epithelial structures.
However, it must also be considered that pro-
teins are very likely to bind rapidly to the par-
ticles, which then may affect the further
metabolic fate of the particles in terms of their
adhesion, residence time on the epithelium or
uptake, and even penetration through the
epithelium. Along this line, the difference of
the two particle materials and surfaces may
have led to binding of those proteins, which
then may have mediated major uptake and
penetration of iridium particles into and
through the epithelium. We already have ﬁrst
evidence that ultraﬁne commercial TiO2 par-
ticles bind more readily to other proteins in the
lung-lining ﬂuid than carbonaceous and amor-
phous silica particles (Semmler etal. 2004a).
Microscopic analyses of phagocytic and
nonphagocytic cells incubated with different
particle types showed that macrophages take
up ﬁne and ultraﬁne polystyrene microspheres
and that treatment with cytD inhibits the
uptake of 1.0-µm particles, but not uptake of
the smaller particles, by these cells. Ultraﬁne
polystyrene and gold particles also entered
RBCs and were not membrane bound.
The mechanisms of intracellular uptake
of macromolecules, particles, and even cells
are subsumed as endocytosis. Material to be
ingested is progressively enclosed by the
plasma membrane, which eventually detaches
to form an endocytic vesicle. Phagocytosis and
pinocytosis are distinguished by the size of
Geiser et al.
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Figure 3. (A) CLSM micrographs of fluorescent polystyrene spheres (1, 0.2, and 0.078 µm) taken up by
macrophages in the absence (–) or presence (+) of cytD (bar = 2 µm); F-actin is shown in red, and particles are
green. The xy and xz projections allow clear differentiation between internalized (arrows) and extracellular
(arrowheads) particles; projections are indicated by open arrowheads. (B) Particle uptake by macrophages in
the absence and presence of cytD. Data are expressed as mean ± SD of three to four experiments scanning
30–50 cells each by CLSM. endocytic vesicles formed. Phagocytosis, a
receptor-mediated, actin-based process, is
characteristic for neutrophils, macrophages,
and dendritic cells. It is the main mechanism
for the clearance of insoluble 1- to 3-µm par-
ticles from the alveoli. Pinocytosis involves the
ingestion of fluid and solutes via vesicles of
about 100 nm in diameter. There are at least
four basic mechanisms, most of which can be
demonstrated in lungs and involve specific
receptor–ligand interactions: a) macro-
pinocytosis, b) clathrin-mediated, actin-based
endocytosis, c) caveolae-mediated endo- or
transcytosis, and d) clathrin- and caveolae-
independent endocytosis (Conner and Schmid
2003). Kruth etal. (1999) described an addi-
tional endocytic process, patocytosis, in which
hydrophobic polystyrene particles < 0.5 µm
are transported through induced plasma mem-
brane channels into an extensive labyrinth of
interconnected membrane-bound compart-
ments. None of these endocytic pathways, all
of which include vesicle formation, is likely to
account for the translocation of UFPs in our
study, as intracellularly localized particles were
not membrane bound. Moreover, because
RBCs contained UFPs and cytD treatment of
macrophages did not prevent UFP transloca-
tion into these cells, particle uptake by any
actin-based mechanism can also be excluded.
Transport via pores, as suggested for lung–
blood substance exchange (Conhaim etal.
1988; Hermans and Bernard 1999), is another
potential mechanism for UFP translocation.
TiO2 particles may diffuse through such pores.
A transport mechanism by diffusion is consis-
tent with the observed spatial distribution of
UFPs in our inhalation study. Thus far, signal-
mediated transport via pores has been demon-
strated only for ultraﬁne gold particles of up to
39 nm in diameter, through the nuclear pore
complex in Xenopus oocytes, where transport
velocities depended on particle size (Panté and
Kann 2002).
Passive uptake (not triggered by receptor–
ligand interactions) may also occur by electro-
static, Van der Waals, or steric interactions,
subsumed under “adhesive interactions”
(Rimai etal. 2000). Rimai et al. showed that
8-µm glass particles were approximately 90%
engulfed by a polystyrene substrate, compared
with 22-µm particles, which were only 30%
engulfed. However, the influence of particle
size on their engulfment was not clarified in
these publications.
Several concepts for the nonspecific
engulfment of particles through interfacial
structures (including cell membranes) have
been suggested. A thermodynamic model
using the “wettability criterion” was successful
in predicting passive particle uptake, although
it did not take into account the elastic proper-
ties of the cell membrane (Chen etal. 1997).
In another thermodynamic analysis combined
with a molecular dynamics simulation, Bresme
and Quirke (1999) showed that line tension
influences the wetting behavior of nanopar-
ticles at liquid–vapor and liquid–liquid inter-
faces. These authors found negative line
tension values for particles of a few nanometers
in diameter, but positive values for those an
order of magnitude larger. A negative line ten-
sion favors the initial wetting of a spherical par-
ticle after its approach to an interface.
Shanahan (1990) studied the engulfment
of solid-surface heterogeneities equivalent to
particles in the nanometer range by unbal-
anced capillary forces (free energy pertur-
bations). Thermal capillary waves cause ﬂuid
droplets to coalesce with a ﬂuid substrate by
ﬁlm drainage at the interface, breakage of the
film, and intrusion of the particle into the
bulk phase (Aarts etal. 2004). Thus, thermal
capillary fluctuations may enhance particle
transport through cell membranes.
Experimental results demonstrate consis-
tently greater immersion of smaller particles
than larger ones into a liquid substrate
covered by surfactant film in vitro as well as
in situ in airways. These results support the
concept that line tension plays a significant
role in particle displacement (Geiser etal.
2000; Schürch etal. 1999).
It remains to be determined which chemi-
cal and physical properties of membranes and
particles are responsible for the translocation of
UFPs in vivo. Interestingly, we did not see any
difference in particle uptake in vitro with
respect to differing surface charges or surface
chemistry when we used three different particle
types: a metal, a metal oxide, and a synthetic
polymeric material (data not shown). However,
these particles were added to the cells in suspen-
sion and did not approach the cells from the air
or require passage through a surfactant film
ﬁrst, as in the in vivo inhalation experiments. In
these in vivo experiments, electrostatic inter-
actions are likely important for particle deposi-
tion and subsequent retention.
In summary, UFPs of various materials can
cross any cellular membrane, but neither endo-
cytosis, which is based on vesicle formation,
nor any actin-based mechanisms are likely to
account for UFP translocation into the cell.
Ultrafine particle distribution in lungs
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Figure 4. (A) CLSM micrographs of ﬂuorescent polystyrene spheres taken up by RBCs. Autoﬂuorescence of the
cells is shown in red, and particles are green (bar = 2 µm). The xy and xz projections allow clear differentiation
between internalized (arrows) and extracellular (arrowheads) particles; open arrowheads mark the position of
the projections. (B, C) TEM micrographs showing uptake of 0.025 µm gold particles by RBCs; the particles are
not membrane bound (arrows). (B) Bar = 1 µm. (C) Higher magniﬁcation of portion of (B); bar = 0.2 µm. Geiser et al.
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Our results from the inhalation experiments
with TiO2 particles point to a transport mech-
anism that includes adhesive interactions or, in
terms of thermodynamics, interfacial and line
tension effects. In addition, particle diffusion
and uptake promoted by thermal capillary
waves might play a role in particle transport
through membranes. After the deposition of
nanometer-size particles, their further fate may
be largely independent from particle surface
chemistry and charge.
Consequently, it is a possible fate of
inhaled ambient UFPs that they are transferred
from the lungs to most other organs. In a ﬁrst
analysis of ultrathin sections from hearts of the
same rats, we found ultraﬁne TiO2 particles in
the connective tissue, that is, within ﬁbroblasts
(data not shown). There may be no means on
the cellular level to prevent, inﬂuence, or direct
their uptake. Moreover, the toxic potential of
UFPs is greatly enhanced by their free location
and movement within cells, which promote
interactions with intracellular proteins and
organelles and even the nuclear DNA.
Potential health implications of our ﬁnd-
ings are related not only to ambient UFPs but
also to engineered “nanoscaled particles,”
which may be released into our environment
during their production, transport, and aging,
or during waste disposal (The Royal Society
2004). Routes of exposure to nanomaterials
include oral, cutaneous, and inhalative uptake,
the latter being addressed in the present study.
Although the number of particles translocated
into the cells may vary substantially (Nanosafe
2004) according to their physicochemical
properties, the data of the present study
strongly suggest that adverse health outcomes
associated with the uncontrolled presence of
nanoscale particles in tissues require further
attention. 
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